Triazolam
Product Images NDC 67544-725

3 FDA label images from Aphena Pharma Solutions - Tennessee, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Triazolam (NDC 67544-725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (39fcc5db A223 46d6 A746 022fdd35210d 01)

Structural Formula (39fcc5db A223 46d6 A746 022fdd35210d 01)
Chemical structure of Triazolam showing a triazolobenzodiazepine core with chlorine substitutions on the aromatic rings.*
FDA Label Image

Bottle Label 0.25mg (67544 725)

Bottle Label 0.25mg (67544 725)
Label for Triazolam 0.25 mg tablets, containing 30 tablets per package. The manufacturer is Roxane Laboratories, with repackaging by Aphena Pharma Solutions - Tennessee, Inc., located in Cookeville, TN. The label includes storage instructions, a warning that the drug may be habit-forming, and designation as a C-IV controlled substance with prescription only status.*
FDA Label Image

Aphena Pharma Solutions (TN)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.